Pierceton, IN, United States of America

Krista Toler

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Krista Toler

Introduction

Krista Toler is an accomplished inventor based in Pierceton, IN (US). She has made significant contributions to the field of medical treatments, particularly in the area of collagen defects and peripheral vascular disease. With a total of 3 patents, her work showcases her dedication to advancing healthcare solutions.

Latest Patents

Krista's latest patents include innovative methods for treating collagen defects using protein solutions. These methods involve stimulating collagen production and chondrocyte production at the site of a defect. The treatment includes administering at least two proteins from a specific group, which includes IL-1ra, sTNF-RI, sTNF-RII, IGF-I, EGF, HGF, PDGF-AB, PDGF-BB, VEGF, TGF-β1, and sIL-1RII. Additionally, she has developed methods for treating peripheral vascular disease, which also utilize protein solutions and may include white blood cells, platelets, and concentrated bone marrow aspirate.

Career Highlights

Throughout her career, Krista has worked with notable companies such as Biomet Biologics, LLC and Biomet Manufacturing Corporation. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking medical innovations.

Collaborations

Krista has collaborated with talented individuals in her field, including Jennifer E Woodell-May and Matthew D Landrigan. These partnerships have further enhanced her research and development efforts.

Conclusion

Krista Toler's innovative work in medical treatments demonstrates her commitment to improving patient outcomes. Her patents reflect her expertise and dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…